Scholars Central

Conference abstractPublished 2 Nov 2016

Correlation between antifungals susceptibility of Cryptococcus spp. and outcome of patients with HIV/ AIDS with cryptococcal meningitis

Authors: Marcia de Souza Carvalho Melhem, Oscar Jose Chagas, Renata Buccheri, Maria Walderez Szeszs, Marilena dos Anjos Martins, Lidiane de Oliveira, Dulcilena de Matos Castro e Silva, Daniel Wagner de Castro Lima Santos

Adolfo Lutz Institute, Brazil Emilio Ribas Research Institute, Brazil

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cryptococcal meningitis is one of the most common opportunistic infections (OIs) in HIV patients and affects one million people per year worldwide, resulting in 625,000 deaths. The aim of our study was to examine the association between the clinical and laboratorial findings of cryptococcal meningitis cases with antifungal minimum inhibitory concentration (MICs) and molecular types of the etiological agents and risk factors associated with in-hospital mortality. Data from 34 patients were reviewed, retrospectively. Regarding the susceptibility test for fluconazole (FLU), using a cutoff of 8 Ã?¼g/mL and 16 Ã?¼g/mL, there were no significant differences between clinical presentation, cytological analyses of CSF, time to sterilize the CSF, isolation of fungus at another site, molecular type, previous diagnosis of cryptococcal meningitis or the use of FLU and overall mortality. There was a statistical association between mortality and patients who did not have sterilized CSF (p=0.002) when lacking of neurosurgical shunt (p=0.021) and in those who presented with other OIs (p=0.037). In addition, patients who died presented with a higher yeast count (median 1720 cells/mcL) in the first CSF level than those who survived (median 351 cells/mcL) (p=0.021). Patients who presented with yeast cell counts >400/mm3 were associated with greater lethality when compared with âÂ?¤400 (p=0.014). We concluded that cryptococcal meningitis is difficult to manage and that the aspects associated with greater mortality should be analyzed carefully. The clinical role of MIC is uncertain, and there is no good evidence for its use in routine practice.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Infectious Diseases & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases & Therapy
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Marcia de Souza Carvalho Melhem”
  • BylineArticles whose byline prints “Oscar Jose Chagas”
  • BylineArticles whose byline prints “Renata Buccheri”
  • BylineArticles whose byline prints “Maria Walderez Szeszs”
  • BylineArticles whose byline prints “Marilena dos Anjos Martins”
  • BylineArticles whose byline prints “Lidiane de Oliveira”
  • BylineArticles whose byline prints “Dulcilena de Matos Castro e Silva”
  • BylineArticles whose byline prints “Daniel Wagner de Castro Lima Santos”